GRAMD1B and infection: Tissue burden determined by qPCR was also evaluated after infection with R. delemar, and ibrexafungerp mono- or combination-therapy reduced mice lung and brain fungal burden with the combination of ibrexafungerp + LAMB, resulting in the lowest fungal tissue burden when compared with placebo or monotherapy.